Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Radionuclide Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Medicine
1.2.3 Inhibitor
1.3 Market by Application
1.3.1 Global Targeted Radionuclide Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Tumors
1.3.3 Thyroid
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Radionuclide Drug Market Perspective (2018-2033)
2.2 Global Targeted Radionuclide Drug Growth Trends by Region
2.2.1 Targeted Radionuclide Drug Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Targeted Radionuclide Drug Historic Market Size by Region (2018-2023)
2.2.3 Targeted Radionuclide Drug Forecasted Market Size by Region (2024-2033)
2.3 Targeted Radionuclide Drug Market Dynamics
2.3.1 Targeted Radionuclide Drug Industry Trends
2.3.2 Targeted Radionuclide Drug Market Drivers
2.3.3 Targeted Radionuclide Drug Market Challenges
2.3.4 Targeted Radionuclide Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Targeted Radionuclide Drug by Players
3.1.1 Global Targeted Radionuclide Drug Revenue by Players (2018-2023)
3.1.2 Global Targeted Radionuclide Drug Revenue Market Share by Players (2018-2023)
3.2 Global Targeted Radionuclide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Targeted Radionuclide Drug, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Targeted Radionuclide Drug Market Concentration Ratio
3.4.1 Global Targeted Radionuclide Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Radionuclide Drug Revenue in 2022
3.5 Global Key Players of Targeted Radionuclide Drug Head office and Area Served
3.6 Global Key Players of Targeted Radionuclide Drug, Product and Application
3.7 Global Key Players of Targeted Radionuclide Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Radionuclide Drug Breakdown Data by Type
4.1 Global Targeted Radionuclide Drug Historic Market Size by Type (2018-2023)
4.2 Global Targeted Radionuclide Drug Forecasted Market Size by Type (2024-2033)
5 Targeted Radionuclide Drug Breakdown Data by Application
5.1 Global Targeted Radionuclide Drug Historic Market Size by Application (2018-2023)
5.2 Global Targeted Radionuclide Drug Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Targeted Radionuclide Drug Market Size (2018-2033)
6.2 North America Targeted Radionuclide Drug Market Size by Type
6.2.1 North America Targeted Radionuclide Drug Market Size by Type (2018-2023)
6.2.2 North America Targeted Radionuclide Drug Market Size by Type (2024-2033)
6.2.3 North America Targeted Radionuclide Drug Market Share by Type (2018-2033)
6.3 North America Targeted Radionuclide Drug Market Size by Application
6.3.1 North America Targeted Radionuclide Drug Market Size by Application (2018-2023)
6.3.2 North America Targeted Radionuclide Drug Market Size by Application (2024-2033)
6.3.3 North America Targeted Radionuclide Drug Market Share by Application (2018-2033)
6.4 North America Targeted Radionuclide Drug Market Size by Country
6.4.1 North America Targeted Radionuclide Drug Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Targeted Radionuclide Drug Market Size by Country (2018-2023)
6.4.3 North America Targeted Radionuclide Drug Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Targeted Radionuclide Drug Market Size (2018-2033)
7.2 Europe Targeted Radionuclide Drug Market Size by Type
7.2.1 Europe Targeted Radionuclide Drug Market Size by Type (2018-2023)
7.2.2 Europe Targeted Radionuclide Drug Market Size by Type (2024-2033)
7.2.3 Europe Targeted Radionuclide Drug Market Share by Type (2018-2033)
7.3 Europe Targeted Radionuclide Drug Market Size by Application
7.3.1 Europe Targeted Radionuclide Drug Market Size by Application (2018-2023)
7.3.2 Europe Targeted Radionuclide Drug Market Size by Application (2024-2033)
7.3.3 Europe Targeted Radionuclide Drug Market Share by Application (2018-2033)
7.4 Europe Targeted Radionuclide Drug Market Size by Country
7.4.1 Europe Targeted Radionuclide Drug Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Targeted Radionuclide Drug Market Size by Country (2018-2023)
7.4.3 Europe Targeted Radionuclide Drug Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Targeted Radionuclide Drug Market Size (2018-2033)
8.2 China Targeted Radionuclide Drug Market Size by Type
8.2.1 China Targeted Radionuclide Drug Market Size by Type (2018-2023)
8.2.2 China Targeted Radionuclide Drug Market Size by Type (2024-2033)
8.2.3 China Targeted Radionuclide Drug Market Share by Type (2018-2033)
8.3 China Targeted Radionuclide Drug Market Size by Application
8.3.1 China Targeted Radionuclide Drug Market Size by Application (2018-2023)
8.3.2 China Targeted Radionuclide Drug Market Size by Application (2024-2033)
8.3.3 China Targeted Radionuclide Drug Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Targeted Radionuclide Drug Market Size (2018-2033)
9.2 Asia Targeted Radionuclide Drug Market Size by Type
9.2.1 Asia Targeted Radionuclide Drug Market Size by Type (2018-2023)
9.2.2 Asia Targeted Radionuclide Drug Market Size by Type (2024-2033)
9.2.3 Asia Targeted Radionuclide Drug Market Share by Type (2018-2033)
9.3 Asia Targeted Radionuclide Drug Market Size by Application
9.3.1 Asia Targeted Radionuclide Drug Market Size by Application (2018-2023)
9.3.2 Asia Targeted Radionuclide Drug Market Size by Application (2024-2033)
9.3.3 Asia Targeted Radionuclide Drug Market Share by Application (2018-2033)
9.4 Asia Targeted Radionuclide Drug Market Size by Region
9.4.1 Asia Targeted Radionuclide Drug Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Targeted Radionuclide Drug Market Size by Region (2018-2023)
9.4.3 Asia Targeted Radionuclide Drug Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 POINT Biopharma
11.1.1 POINT Biopharma Company Details
11.1.2 POINT Biopharma Business Overview
11.1.3 POINT Biopharma Targeted Radionuclide Drug Introduction
11.1.4 POINT Biopharma Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.1.5 POINT Biopharma Recent Developments
11.2 Telix
11.2.1 Telix Company Details
11.2.2 Telix Business Overview
11.2.3 Telix Targeted Radionuclide Drug Introduction
11.2.4 Telix Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.2.5 Telix Recent Developments
11.3 ITM AG
11.3.1 ITM AG Company Details
11.3.2 ITM AG Business Overview
11.3.3 ITM AG Targeted Radionuclide Drug Introduction
11.3.4 ITM AG Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.3.5 ITM AG Recent Developments
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Targeted Radionuclide Drug Introduction
11.4.4 Bayer AG Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.4.5 Bayer AG Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Targeted Radionuclide Drug Introduction
11.5.4 Novartis Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.5.5 Novartis Recent Developments
11.6 Lantheus
11.6.1 Lantheus Company Details
11.6.2 Lantheus Business Overview
11.6.3 Lantheus Targeted Radionuclide Drug Introduction
11.6.4 Lantheus Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.6.5 Lantheus Recent Developments
11.7 Curium Pharma
11.7.1 Curium Pharma Company Details
11.7.2 Curium Pharma Business Overview
11.7.3 Curium Pharma Targeted Radionuclide Drug Introduction
11.7.4 Curium Pharma Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.7.5 Curium Pharma Recent Developments
11.8 Fusion Pharmaceuticals
11.8.1 Fusion Pharmaceuticals Company Details
11.8.2 Fusion Pharmaceuticals Business Overview
11.8.3 Fusion Pharmaceuticals Targeted Radionuclide Drug Introduction
11.8.4 Fusion Pharmaceuticals Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.8.5 Fusion Pharmaceuticals Recent Developments
11.9 RadioMedix, Inc.
11.9.1 RadioMedix, Inc. Company Details
11.9.2 RadioMedix, Inc. Business Overview
11.9.3 RadioMedix, Inc. Targeted Radionuclide Drug Introduction
11.9.4 RadioMedix, Inc. Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.9.5 RadioMedix, Inc. Recent Developments
11.10 Convergent Therapeutics
11.10.1 Convergent Therapeutics Company Details
11.10.2 Convergent Therapeutics Business Overview
11.10.3 Convergent Therapeutics Targeted Radionuclide Drug Introduction
11.10.4 Convergent Therapeutics Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.10.5 Convergent Therapeutics Recent Developments
11.11 IONETIX
11.11.1 IONETIX Company Details
11.11.2 IONETIX Business Overview
11.11.3 IONETIX Targeted Radionuclide Drug Introduction
11.11.4 IONETIX Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.11.5 IONETIX Recent Developments
11.12 Clarity Pharmaceuticals
11.12.1 Clarity Pharmaceuticals Company Details
11.12.2 Clarity Pharmaceuticals Business Overview
11.12.3 Clarity Pharmaceuticals Targeted Radionuclide Drug Introduction
11.12.4 Clarity Pharmaceuticals Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.12.5 Clarity Pharmaceuticals Recent Developments
11.13 RayzeBio, Inc
11.13.1 RayzeBio, Inc Company Details
11.13.2 RayzeBio, Inc Business Overview
11.13.3 RayzeBio, Inc Targeted Radionuclide Drug Introduction
11.13.4 RayzeBio, Inc Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.13.5 RayzeBio, Inc Recent Developments
11.14 AmbioPharm
11.14.1 AmbioPharm Company Details
11.14.2 AmbioPharm Business Overview
11.14.3 AmbioPharm Targeted Radionuclide Drug Introduction
11.14.4 AmbioPharm Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.14.5 AmbioPharm Recent Developments
11.15 Bracco Imaging
11.15.1 Bracco Imaging Company Details
11.15.2 Bracco Imaging Business Overview
11.15.3 Bracco Imaging Targeted Radionuclide Drug Introduction
11.15.4 Bracco Imaging Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.15.5 Bracco Imaging Recent Developments
11.16 Navidea
11.16.1 Navidea Company Details
11.16.2 Navidea Business Overview
11.16.3 Navidea Targeted Radionuclide Drug Introduction
11.16.4 Navidea Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.16.5 Navidea Recent Developments
11.17 China Isotope & Radiation Corporation
11.17.1 China Isotope & Radiation Corporation Company Details
11.17.2 China Isotope & Radiation Corporation Business Overview
11.17.3 China Isotope & Radiation Corporation Targeted Radionuclide Drug Introduction
11.17.4 China Isotope & Radiation Corporation Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.17.5 China Isotope & Radiation Corporation Recent Developments
11.18 Yantai Dongcheng
11.18.1 Yantai Dongcheng Company Details
11.18.2 Yantai Dongcheng Business Overview
11.18.3 Yantai Dongcheng Targeted Radionuclide Drug Introduction
11.18.4 Yantai Dongcheng Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.18.5 Yantai Dongcheng Recent Developments
11.19 Grand Pharma
11.19.1 Grand Pharma Company Details
11.19.2 Grand Pharma Business Overview
11.19.3 Grand Pharma Targeted Radionuclide Drug Introduction
11.19.4 Grand Pharma Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.19.5 Grand Pharma Recent Developments
11.20 Hengrui Medicine
11.20.1 Hengrui Medicine Company Details
11.20.2 Hengrui Medicine Business Overview
11.20.3 Hengrui Medicine Targeted Radionuclide Drug Introduction
11.20.4 Hengrui Medicine Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.20.5 Hengrui Medicine Recent Developments
11.21 Yunnan Baiyao Group
11.21.1 Yunnan Baiyao Group Company Details
11.21.2 Yunnan Baiyao Group Business Overview
11.21.3 Yunnan Baiyao Group Targeted Radionuclide Drug Introduction
11.21.4 Yunnan Baiyao Group Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.21.5 Yunnan Baiyao Group Recent Developments
11.22 SmartNuclide Biopharma
11.22.1 SmartNuclide Biopharma Company Details
11.22.2 SmartNuclide Biopharma Business Overview
11.22.3 SmartNuclide Biopharma Targeted Radionuclide Drug Introduction
11.22.4 SmartNuclide Biopharma Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.22.5 SmartNuclide Biopharma Recent Developments
11.23 Sinotau
11.23.1 Sinotau Company Details
11.23.2 Sinotau Business Overview
11.23.3 Sinotau Targeted Radionuclide Drug Introduction
11.23.4 Sinotau Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.23.5 Sinotau Recent Developments
11.24 Hexin Pharmaceutical
11.24.1 Hexin Pharmaceutical Company Details
11.24.2 Hexin Pharmaceutical Business Overview
11.24.3 Hexin Pharmaceutical Targeted Radionuclide Drug Introduction
11.24.4 Hexin Pharmaceutical Revenue in Targeted Radionuclide Drug Business (2018-2023)
11.24.5 Hexin Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Targeted Radionuclide Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Medicine
Table 3. Key Players of Inhibitor
Table 4. Global Targeted Radionuclide Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Targeted Radionuclide Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Targeted Radionuclide Drug Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Targeted Radionuclide Drug Market Share by Region (2018-2023)
Table 8. Global Targeted Radionuclide Drug Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Targeted Radionuclide Drug Market Share by Region (2024-2033)
Table 10. Targeted Radionuclide Drug Market Trends
Table 11. Targeted Radionuclide Drug Market Drivers
Table 12. Targeted Radionuclide Drug Market Challenges
Table 13. Targeted Radionuclide Drug Market Restraints
Table 14. Global Targeted Radionuclide Drug Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Targeted Radionuclide Drug Revenue Share by Players (2018-2023)
Table 16. Global Top Targeted Radionuclide Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Drug as of 2022)
Table 17. Global Targeted Radionuclide Drug Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Targeted Radionuclide Drug Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Targeted Radionuclide Drug, Headquarters and Area Served
Table 20. Global Key Players of Targeted Radionuclide Drug, Product and Application
Table 21. Global Key Players of Targeted Radionuclide Drug, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Targeted Radionuclide Drug Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Targeted Radionuclide Drug Revenue Market Share by Type (2018-2023)
Table 25. Global Targeted Radionuclide Drug Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Targeted Radionuclide Drug Revenue Market Share by Type (2024-2033)
Table 27. Global Targeted Radionuclide Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Targeted Radionuclide Drug Revenue Share by Application (2018-2023)
Table 29. Global Targeted Radionuclide Drug Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Targeted Radionuclide Drug Revenue Share by Application (2024-2033)
Table 31. North America Targeted Radionuclide Drug Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Targeted Radionuclide Drug Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Targeted Radionuclide Drug Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Targeted Radionuclide Drug Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Targeted Radionuclide Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Targeted Radionuclide Drug Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Targeted Radionuclide Drug Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Targeted Radionuclide Drug Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Targeted Radionuclide Drug Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Targeted Radionuclide Drug Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Targeted Radionuclide Drug Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Targeted Radionuclide Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Targeted Radionuclide Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Targeted Radionuclide Drug Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Targeted Radionuclide Drug Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Targeted Radionuclide Drug Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Targeted Radionuclide Drug Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Targeted Radionuclide Drug Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Targeted Radionuclide Drug Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Targeted Radionuclide Drug Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Targeted Radionuclide Drug Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Targeted Radionuclide Drug Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Targeted Radionuclide Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Targeted Radionuclide Drug Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Targeted Radionuclide Drug Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Targeted Radionuclide Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size by Country (2024-2033) & (US$ Million)
Table 63. POINT Biopharma Company Details
Table 64. POINT Biopharma Business Overview
Table 65. POINT Biopharma Targeted Radionuclide Drug Product
Table 66. POINT Biopharma Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 67. POINT Biopharma Recent Developments
Table 68. Telix Company Details
Table 69. Telix Business Overview
Table 70. Telix Targeted Radionuclide Drug Product
Table 71. Telix Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 72. Telix Recent Developments
Table 73. ITM AG Company Details
Table 74. ITM AG Business Overview
Table 75. ITM AG Targeted Radionuclide Drug Product
Table 76. ITM AG Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 77. ITM AG Recent Developments
Table 78. Bayer AG Company Details
Table 79. Bayer AG Business Overview
Table 80. Bayer AG Targeted Radionuclide Drug Product
Table 81. Bayer AG Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 82. Bayer AG Recent Developments
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Targeted Radionuclide Drug Product
Table 86. Novartis Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 87. Novartis Recent Developments
Table 88. Lantheus Company Details
Table 89. Lantheus Business Overview
Table 90. Lantheus Targeted Radionuclide Drug Product
Table 91. Lantheus Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 92. Lantheus Recent Developments
Table 93. Curium Pharma Company Details
Table 94. Curium Pharma Business Overview
Table 95. Curium Pharma Targeted Radionuclide Drug Product
Table 96. Curium Pharma Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 97. Curium Pharma Recent Developments
Table 98. Fusion Pharmaceuticals Company Details
Table 99. Fusion Pharmaceuticals Business Overview
Table 100. Fusion Pharmaceuticals Targeted Radionuclide Drug Product
Table 101. Fusion Pharmaceuticals Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 102. Fusion Pharmaceuticals Recent Developments
Table 103. RadioMedix, Inc. Company Details
Table 104. RadioMedix, Inc. Business Overview
Table 105. RadioMedix, Inc. Targeted Radionuclide Drug Product
Table 106. RadioMedix, Inc. Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 107. RadioMedix, Inc. Recent Developments
Table 108. Convergent Therapeutics Company Details
Table 109. Convergent Therapeutics Business Overview
Table 110. Convergent Therapeutics Targeted Radionuclide Drug Product
Table 111. Convergent Therapeutics Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 112. Convergent Therapeutics Recent Developments
Table 113. IONETIX Company Details
Table 114. IONETIX Business Overview
Table 115. IONETIX Targeted Radionuclide Drug Product
Table 116. IONETIX Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 117. IONETIX Recent Developments
Table 118. Clarity Pharmaceuticals Company Details
Table 119. Clarity Pharmaceuticals Business Overview
Table 120. Clarity Pharmaceuticals Targeted Radionuclide Drug Product
Table 121. Clarity Pharmaceuticals Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 122. Clarity Pharmaceuticals Recent Developments
Table 123. RayzeBio, Inc Company Details
Table 124. RayzeBio, Inc Business Overview
Table 125. RayzeBio, Inc Targeted Radionuclide Drug Product
Table 126. RayzeBio, Inc Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 127. RayzeBio, Inc Recent Developments
Table 128. AmbioPharm Company Details
Table 129. AmbioPharm Business Overview
Table 130. AmbioPharm Targeted Radionuclide Drug Product
Table 131. AmbioPharm Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 132. AmbioPharm Recent Developments
Table 133. Bracco Imaging Company Details
Table 134. Bracco Imaging Business Overview
Table 135. Bracco Imaging Targeted Radionuclide Drug Product
Table 136. Bracco Imaging Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 137. Bracco Imaging Recent Developments
Table 138. Navidea Company Details
Table 139. Navidea Business Overview
Table 140. Navidea Targeted Radionuclide Drug Product
Table 141. Navidea Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 142. Navidea Recent Developments
Table 143. China Isotope & Radiation Corporation Company Details
Table 144. China Isotope & Radiation Corporation Business Overview
Table 145. China Isotope & Radiation Corporation Targeted Radionuclide Drug Product
Table 146. China Isotope & Radiation Corporation Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 147. China Isotope & Radiation Corporation Recent Developments
Table 148. Yantai Dongcheng Company Details
Table 149. Yantai Dongcheng Business Overview
Table 150. Yantai Dongcheng Targeted Radionuclide Drug Product
Table 151. Yantai Dongcheng Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 152. Yantai Dongcheng Recent Developments
Table 153. Grand Pharma Company Details
Table 154. Grand Pharma Business Overview
Table 155. Grand Pharma Targeted Radionuclide Drug Product
Table 156. Grand Pharma Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 157. Grand Pharma Recent Developments
Table 158. Hengrui Medicine Company Details
Table 159. Hengrui Medicine Business Overview
Table 160. Hengrui Medicine Targeted Radionuclide Drug Product
Table 161. Hengrui Medicine Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 162. Hengrui Medicine Recent Developments
Table 163. Yunnan Baiyao Group Company Details
Table 164. Yunnan Baiyao Group Business Overview
Table 165. Yunnan Baiyao Group Targeted Radionuclide Drug Product
Table 166. Yunnan Baiyao Group Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 167. Yunnan Baiyao Group Recent Developments
Table 168. SmartNuclide Biopharma Company Details
Table 169. SmartNuclide Biopharma Business Overview
Table 170. SmartNuclide Biopharma Targeted Radionuclide Drug Product
Table 171. SmartNuclide Biopharma Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 172. SmartNuclide Biopharma Recent Developments
Table 173. Sinotau Company Details
Table 174. Sinotau Business Overview
Table 175. Sinotau Targeted Radionuclide Drug Product
Table 176. Sinotau Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 177. Sinotau Recent Developments
Table 178. Hexin Pharmaceutical Company Details
Table 179. Hexin Pharmaceutical Business Overview
Table 180. Hexin Pharmaceutical Targeted Radionuclide Drug Product
Table 181. Hexin Pharmaceutical Revenue in Targeted Radionuclide Drug Business (2018-2023) & (US$ Million)
Table 182. Hexin Pharmaceutical Recent Developments
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Radionuclide Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Targeted Radionuclide Drug Market Share by Type: 2022 VS 2033
Figure 3. Medicine Features
Figure 4. Inhibitor Features
Figure 5. Global Targeted Radionuclide Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Targeted Radionuclide Drug Market Share by Application: 2022 VS 2033
Figure 7. Tumors Case Studies
Figure 8. Thyroid Case Studies
Figure 9. Others Case Studies
Figure 10. Targeted Radionuclide Drug Report Years Considered
Figure 11. Global Targeted Radionuclide Drug Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Targeted Radionuclide Drug Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Targeted Radionuclide Drug Market Share by Region: 2022 VS 2033
Figure 14. Global Targeted Radionuclide Drug Market Share by Players in 2022
Figure 15. Global Top Targeted Radionuclide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Targeted Radionuclide Drug Revenue in 2022
Figure 17. North America Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Targeted Radionuclide Drug Market Share by Type (2018-2033)
Figure 19. North America Targeted Radionuclide Drug Market Share by Application (2018-2033)
Figure 20. North America Targeted Radionuclide Drug Market Share by Country (2018-2033)
Figure 21. United States Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Targeted Radionuclide Drug Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Targeted Radionuclide Drug Market Share by Type (2018-2033)
Figure 25. Europe Targeted Radionuclide Drug Market Share by Application (2018-2033)
Figure 26. Europe Targeted Radionuclide Drug Market Share by Country (2018-2033)
Figure 27. Germany Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Targeted Radionuclide Drug Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Targeted Radionuclide Drug Market Share by Type (2018-2033)
Figure 35. China Targeted Radionuclide Drug Market Share by Application (2018-2033)
Figure 36. Asia Targeted Radionuclide Drug Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Targeted Radionuclide Drug Market Share by Type (2018-2033)
Figure 38. Asia Targeted Radionuclide Drug Market Share by Application (2018-2033)
Figure 39. Asia Targeted Radionuclide Drug Market Share by Region (2018-2033)
Figure 40. Japan Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Targeted Radionuclide Drug Market Share by Country (2018-2033)
Figure 50. Brazil Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Targeted Radionuclide Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. POINT Biopharma Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 57. Telix Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 58. ITM AG Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 59. Bayer AG Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 60. Novartis Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 61. Lantheus Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 62. Curium Pharma Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 63. Fusion Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 64. RadioMedix, Inc. Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 65. Convergent Therapeutics Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 66. IONETIX Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 67. Clarity Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 68. RayzeBio, Inc Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 69. AmbioPharm Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 70. Bracco Imaging Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 71. Navidea Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 72. China Isotope & Radiation Corporation Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 73. Yantai Dongcheng Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 74. Grand Pharma Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 75. Hengrui Medicine Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 76. Yunnan Baiyao Group Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 77. SmartNuclide Biopharma Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 78. Sinotau Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 79. Hexin Pharmaceutical Revenue Growth Rate in Targeted Radionuclide Drug Business (2018-2023)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed